Dr. Yee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Duarte Rd
Duarte, CA 91010
Summary
- Dr. Lisa Yee is a surgical oncologist specializing in breast cancer and cancer prevention in Duarte, CA and is affiliated with multiple hospitals in the area, including City of Hope's Helford Clinical Research Hospital. She received her medical degree from Yale School of Medicine and has been in practice 37 years. She specializes in breast surgical oncology and clinical and translational research in breast cancer prevention and symptom intervention. She has more than 70 publications and over 500 citings.
Education & Training
Mount Sinai Medical Center of FloridaResidency, Surgery, 1989 - 1993
Oregon Health & Science University (OHSU Health)Residency, Surgery, 1986 - 1989
Yale School of MedicineClass of 1986
Yale UniversityClass of 1986
Certifications & Licensure
OR State Medical License 1987 - Present
CA State Medical License 2017 - 2026
OH State Medical License 1996 - 2025
FL State Medical License 1993 - 2016- American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Dietary Fish and Omega 3 Fatty Acids for Breast Cancer Prevention Start of enrollment: 2010 Jul 01
- Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer Start of enrollment: 2013 Jun 01
- Functional Snack Foods With Safflower Oil and Soy in Postmenopausal Women Having Metabolic Syndrome Start of enrollment: 2014 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- Randomized dose-response trial of n-3 fatty acids in hormone receptor negative breast cancer survivors- impact on breast adipose oxylipin and DNA methylation patterns.David E Frankhouser, Todd DeWess, Isabel F Snodgrass, Rachel M Cole, Sarah Steck
Medrxiv. 2024-09-16 - 1 citationsRandomized placebo-controlled, double-blind clinical trial of nanoemulsion curcumin in women with aromatase inhibitor-induced arthropathy: an Alliance/NCORP pilot trial.Maryam Lustberg, Patty Fan-Havard, F Lennie Wong, Kasey Hill, Mitch A Phelps
Breast Cancer Research and Treatment. 2024-05-01 - 6 citationsDietary omega-3 fatty acid intake impacts peripheral blood DNA methylation -anti-inflammatory effects and individual variability in a pilot study.David Frankhouser, Sarah A. Steck, Michael G. Sovic, Martha A. Belury, Qianben Wang
The Journal of Nutritional Biochemistry. 2022-01-01
Press Mentions
Provocative Cancer Therapy Trudges down Road to Federal ApprovalSeptember 16th, 2024- New CBD-Based Drug Offers Hope for Breast Cancer Patients Struggling with Pain: Clinical Trial Kicks OffSeptember 13th, 2024
Grant Support
- Omega 3 Fatty Acids Supplements In Women At High Risk For Breast CancerNational Center For Research Resources2007–2008
- Her2/Neu And Dietary Fat: Interactions In Breast CancerNational Cancer Institute2005–2006
- Fatty Acids And Ppars In Breast Cancer PreventionNational Cancer Institute2000–2005
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
